VALID Act of 2020
Latest action · Mar 5, 2020 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 5, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020
This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
Cosponsors 1
Members who signed on, in the order they did. All signed on Mar 5, 2020.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IN | Larry Bucshon | Original | Mar 5, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 5, 2020 |
Actions 2
Everything that happened, newest first.
- Mar 5, 2020Introduced in House
- Mar 5, 2020Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 44, March 5, 2020, page H1536.
CRS reports 3
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 3
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R47373 | Science and Technology Issues for the 118th Congress Archived | Report | Oct 15, 2024 |
| IF12628 | Regulation of Laboratory-Developed Tests: FDA’s Proposed Rule | Resource | Apr 8, 2024 |
| R46787 | Science and Technology Issues in the 117th Congress Archived | Report | May 5, 2021 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 3404 | VALID Act of 2020 | Identical bill | Mar 5, 2020 |
| HR 4128 | VALID Act of 2021 | Reintroduced Bill | Jun 25, 2021 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
- Short Title(s) as Introduced
- VALID Act of 2020
- Verifying Accurate Leading-edge IVCT Development Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Administrative remedies
- Advisory bodies
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Emergency medical services and trauma care
- Federal preemption
- Food and Drug Administration (FDA)
- Government information and archives
- Health
- Health technology, devices, supplies
- Licensing and registrations
- Medical tests and diagnostic methods
- Performance measurement
- User charges and fees
Text 1
Each version as it was printed, newest first.
- Mar 5, 2020Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.